The paradigm shift for drug delivery systems for oral and maxillofacial implants
Open Access
- 1 January 2018
- journal article
- review article
- Published by Taylor & Francis in Drug Delivery
- Vol. 25 (1) , 1504-1515
Abstract
Along with the development of nanotechnological strategies for biomaterials associated with the prevention of infections, a myriad of clinically unproven techniques have been described to date. In this work, the aim was to perform a critical analysis of the literature available concerning antibacterial biomaterials for oral implantology and to provide a practical derivation for such a purpose. As anti-adhesive strategies may affect osseointegration, they should no longer be recommended for inclusion in this class of biomaterials, despite promising results in biomedical engineering for other, non-bone load bearing organs. Targeted, antibacterial drug delivery is most likely desirable in the case of intraosseous implants. Interfering factors such as the oral cavity environment, saliva, the bacterial microbiome, as well as, the characteristics of the alveolar mucosa and peri-implant space must be taken into account when calculating the local pharmacokinetics for antibacterial coatings. Effective release is crucial for tailoring antibacterial implant longevity providing minimal inhibitory concentration (MIC) for the desired amount of time, which for oral implants, should be at least the cumulative time for the osseointegration period and functional loading period within the tissues. These parameters may differ between the implant type and its anatomical site. Also, the functional drug concentration in the peri-implant space should be calculated as the amount of the drug released from the implant surface including the concentration of the drug inactivated by biological fluids of the peri-implant space or saliva flow throughout the effective release time.Keywords
This publication has 75 references indexed in Scilit:
- Inhibition by Local Bupivacaine-Releasing Microspheres of Acute Postoperative Pain from Hairy Skin IncisionAnesthesia & Analgesia, 2013
- Targeting the bacteria–host interfaceVirulence, 2013
- The future of biologic coatings for orthopaedic implantsBiomaterials, 2013
- Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of AntibioticsAntibiotics, 2013
- Mixed Red-Complex Bacterial Infection in PeriodontitisInternational Journal of Dentistry, 2013
- Prevention and management of external fixator pin track sepsisStrategies in Trauma and Limb Reconstruction, 2012
- Nanoparticles for Local Drug Delivery to the Oral Mucosa: Proof of Principle StudiesPharmaceutical Research, 2010
- Effect of Subinhibitory Concentrations of Antibiotics on Intrachromosomal Homologous Recombination in Escherichia coliAntimicrobial Agents and Chemotherapy, 2009
- Oral Mucosal Drug DeliveryClinical Pharmacokinetics, 2002
- Drug Delivery Systems 4. Implants in Drug DeliveryThe Journal of Clinical Pharmacology, 1990